◆ SpookStack

FD-302 (Rev. 10-6-95) -1 - FEDERAL BUREAU OF INVESTIGATION ALL INFORMATION CONTAINED HEREIN IS UNCLASSIFIED DATE 12-16-2008 BY 60324 UC BAW/DK/RYS Date of transcription 01/16/2007 On Januaky 12, 2007, date of b6 birth: SSAN : was interviewed at b7C interviewing agents and the purpose of the interview,. provided the following information: works at the United States Army Medical Research. Institute of Infectious Diseases (usAMRIID) in the b6 under lis in Building b7C indicated that recently there is very little talk of the AMERITHRAX investigation throughout UsAMRIID. When referring to the dry aerosol study that was. conducted by the described it as a side project which occurred over a relatively short time period believes it was explained that The purpose of this project was to bridge the gap between use of which in the real world would be caused by a dry aerosol. elaborated that if conducting aerosol vaccine challenges using a wet suspension of Ba spores did not accurately reflect a disease (e.g. inhalational anthrax) caused by a dry aerosol then the results of the model had limited value. The purpose of the bridging study was to demonstrate that a wet aerosol vaccine challenge was a suitable model. USAMRIID was directed by! to attempt to aerosolize Work performed by on this project was. conducted in room of building. designated area at the time.. explained that during this project Jinquired b6 about possibility of using a dried biological. agent. However, the b7C administration at the UsAMRIiD denied the use of dried biological aqents due to their dual use perception. Investigation on 01/12/2007 at File # 279A-WF-222936-USAMRIID - lQ Q Date dictated 01/16/2007 SA b6 by SA b7C This document contains neither recommendations nor conclusions of the FBl. It is the property of the FBI and is loaned to your agency; it and its contents are not to be distributed outside your agency.